The Global Non-Small Cell Lung Cancer Market size is projected to grow at a CAGR of around 11.2% during the forecast period, i.e., 2022-27. According to MarkNtel Advisors Study.

Global Non-Small Cell Lung Cancer Market Driver:

The single biggest driver of growth in the Global Non-Small Cell Lung Cancer (NSCLC) market is the continued shift from broadly cytotoxic chemotherapy to precision, biomarker-guided medicine: widespread adoption of PD-1/PD-L1 immune checkpoint inhibitors and an expanding set of targeted drugs (EGFR, ALK, ROS1, BRAF, and newer targets such as KRAS G12C), coupled with increasing uptake of comprehensive molecular and PD-L1 testing. This is expanding treatable patient populations, improving survival outcomes, enabling high-value combination regimens, and powering strong commercial uptake and pipeline investment. 

Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/non-small-cell-lung-cancer-market.html

Key Market Reports Highlights

·        Market Dimensions & Projections

·        Pricing Evaluation

·        Recent Strategic Moves by Companies

·        Primary Stakeholders

·        Import/Export Trend Analysis

·        Competitive Landscape Assessment

·        Emerging Opportunities

·        Market Trends and Indicators

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Browse Full Report including(TOC+ List of Table and Figures) : https://www.marknteladvisors.com/research-library/non-small-cell-lung-cancer-market.html

Global Non-Small Cell Lung Cancer Market Segmentation:

The market report categorizes the market based on different segments and geographical analysis.

Study Timeline:

-Base Year: 2021

-Historical Period: 2017 to 2020

-Forecast Period: 2022 to 2027

• By Diagnosis
• Blood & Urine Tests
• Imaging
• Biopsy
• Sputum Cytology
• Bronchoscopy
• By Cancer Type
• Squamous Cell Carcinoma (SCC)
• Large Cell Carcinoma (LCC)
• Adenocarcinoma
• By Treatment
• Surgery
• Chemotherapy
• Immunotherapy
• Immune Checkpoint Inhibitors
• PD-1/PD-L1 Inhibitors
• CTLA-4 Inhibitor
• Radiation Therapy
• External Beam Radiation Therapy
• Brachytherapy (Internal Radiation Therapy)
• Radiofrequency Ablation (RFA)
• Targeted Therapy
• By End-User
• Hospitals
• Cancer Centers
• Others (Ambulatory Surgery Centers, etc.)
• By Region
• North America
• South America
• Europe
• Middle East & Africa
• Asia-Pacific

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including - Allergan (AbbVie), AstraZeneca PLC, Boehringer Ingelheim, Bristol Myers Squibb, Eisai Co., Ltd, Eli Lilly and Company, GlaxoSmithKline PLC, F. Hoffmann-La Roche AG, Merck & Co., Inc., Novartis International AG, Other are looking forward to strengthening their market positions.

Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/talk-to-our-consultant/non-small-cell-lung-cancer-market.html

Data-Driven Insights Backed by Proven Research

We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.

From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.

About Us –

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us

MarkNtel Advisors

Email: sales@marknteladvisors.com

Website: www.marknteladvisors.com

Latest Press Release - https://www.marknteladvisors.com/press-release